Advertisement

Malignant Melanoma of the Breast

  • Sarah Norton
  • Matthew Sills
  • Gerard O’Donoghue
Chapter

Abstract

A diagnosis of malignant melanoma of the breast is rare. There are only a few reported cases in the literature. Nonetheless, it remains an important differential diagnosis for pigmented lesions of the breast. The clinical presentation is similar to that of malignant melanoma elsewhere on the skin. Clinicians should suspect the diagnosis if there is a change in size, pigmentation, ulceration and bleeding present in a pre-existing nevus. Once a diagnosis of malignant melanoma of the breast has been made, prognosis will depend on tumour size, Clarke’s level, Breslow thickness, location of the lesion, ulceration and whether metastases are present. Sentinel lymph node biopsy (SLNB) with lymphoscintigraphic mapping is a useful, minimally invasive procedure used for survival and prognosis prediction in these patients.

References

  1. 1.
    Godar DE. Worldwide increasing incidences of cutaneous malignant melanoma. J Skin Cancer. 2011;2011:858425.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lens MB, Dawes M. Global perspectives of contemporary epidemiological trend of cutaneous malignant melanoma. Br J Dermatol. 2004;150(2):179–85.CrossRefPubMedGoogle Scholar
  3. 3.
    Merrill SJ, Subramanian M, Godar DE. Worldwide cutaneous malignant melanoma incidences analysed by sex, age, and skin type over time (1955–2007): is HPV infection of androgenic hair follicular melanocytes a risk factor for developing melanoma exclusively in people of European-ancestry? Dermatoendocrinology. 2016;8(1):e1215391.CrossRefGoogle Scholar
  4. 4.
    Merrill SJ, Ashrafi S, Subramanian M, et al. Exponentially increasing incidences of cutaneous malignant melanoma in Europe correlate with low personal annual UV doses and suggests two major risk factors. Dermatoendocrinology. 2015;7(1):e1004018.CrossRefGoogle Scholar
  5. 5.
    National Cancer Registry. Cancer in Ireland 1994–2012: annual report of the National Cancer Registry. Cork, Ireland: NCR; 2014.Google Scholar
  6. 6.
    Sills M, Norton S, Landers R, et al. Malignant melanoma of the breast: a case report. J Cancer Biol Res. 2016;4(1):1075.Google Scholar
  7. 7.
    Yujun HE, Jianghong MOU, Donglin LOU, Bo GAO, Yyuan WEN. Primary malignant melanoma of the breast: a case report and review of the literature. Oncol Lett. 2014;8:238–40.CrossRefGoogle Scholar
  8. 8.
    Pressman PI. Malignant melanoma and the breast. Cancer. 1973;31:784–92.CrossRefPubMedGoogle Scholar
  9. 9.
    Vasudevan JA, Somanathan T, Mathews A, Kattoor J. Malignant melanoma of breast: a unique case with diagnostic dilemmas. Indian J Pathol Microbiol. 2014;57:287–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Balch CM, Gershenwald JE, Soong SJ, Thompson JF, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Drummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):126–32.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Sarah Norton
    • 1
  • Matthew Sills
    • 2
  • Gerard O’Donoghue
    • 2
  1. 1.University Hospital WaterfordWaterfordIreland
  2. 2.Department of SurgeryUniversity Hospital WaterfordWaterfordIreland

Personalised recommendations